Tumor associated glycoprotein (TAG) 12: a new tumor marker in breast cancer.
We compared the preoperative sensitivity of tumor associated glycoprotein (TAG) 12 of 128 primary breast cancer patients with the established tumor marker CA 15-3 and received a similar, even slightly higher sensitivity. In the follow-up the first results showed in some cases different courses of Tag 12 values especially in cases without expression of CA 15-3 whilst in some cases we found an earlier response of TAG 12 to a progression of the disease.
Heinze
T
T
Department of Gynecology, Endocrinology, Charité Campus Virchow-Klinikum, Humboldt-University Berlin, D-13344 Berlin, Germany.
Lichtenegger
W
W
D000951:Antigens, Neoplasm / Q000097:blood*; D014408:Biomarkers, Tumor / Q000097:blood*; D001943:Breast Neoplasms / Q000097:blood / Q000175:diagnosis*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D018396:Mucin-1 / Q000097:blood; D011379:Prognosis
D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D018396:Mucin-1; C069631:TAG 12